Huang et al., Shenyang, China. In Antonie Van Leeuwenhoek, Dec 2015
Two novel actinobacteria, designated strains YIM 101617(T) and YIM 101632(T), were isolated from Lama pacos (alpaca) and Viverra zibetha (civet) faeces in Yunnan Wild Animal Park in Yunnan province, southwestern China.
Aba et al., Tandil, Argentina. In Reprod Domest Anim, Dec 2015
Endometrial expression of oestrogen receptor-α (ERα), progesterone receptor (PR) and cyclooxigenase-2 (COX-2) was evaluated in non-pregnant and pregnant llamas during the period when luteolysis/maternal recognition of pregnancy is expected to occur.
Kerwin et al., Toronto, Canada. In Expert Rev Respir Med, Oct 2015
Results from clinical studies suggest that dual bronchodilator therapy with long-acting muscarinic receptor antagonists (LAMAs) and long-acting β2 adrenergic receptor agonists (LABAs) may provide additional benefit over LAMA or LABA monotherapy without additive effects on safety and tolerability.
Maselli et al., Catanzaro, Italy. In Ther Clin Risk Manag, 2014
In particular, these therapeutic agents are mostly long-acting compounds utilized via inhalation, and include LAMA (long-acting muscarinic receptor antagonists) and LABA (long-acting β2-adrenoceptor agonists).
Price et al., Toronto, Canada. In Expert Opin Pharmacother, 2014
EXPERT OPINION: For patients with COPD who do not have ACOS, a LAMA/LABA combination may be an appropriate starting therapy, apart from those with mild disease who can be managed with a single long-acting bronchodilator.
Kupczyk et al., Łódź, Poland. In Pneumonol Alergol Pol, 2014
New treatment options for patients with asthma include: ultra-long-acting beta2-agonists, long-acting muscarine receptor antagonists (LAMA), monoclonal antibodies, and non-pharmacological interventions.
German CML Study Group et al., Mannheim, Germany. In Plos One, 2014
We investigated the influence of p210BCR-ABL breakpoint variants and imatinib treatment on expression and proteolytic activity of Separase as measured with a specific fluorogenic assay on CML cell lines (b2a2: KCL-22, BV-173; b3a2: K562, LAMA-84).